Schizophrenia is a severe psychiatric disorder primarily involving symptoms of psychosis.
Antipsychotic administration is primarily relied upon by clinicians to treat and manage …

Introduction The relationship between genetic polymorphisms of antipsychotic drug-
metabolizing agents and drug receptors has been often investigated. DNA methylation is a …

Antipsychotic response in schizophrenia is a complex, multifactorial trait influenced by
pharmacogenetic factors. With genetic studies thus far providing little biological insight or …

Aim: To explore possible differences in genome-wide methylation between schizophrenia
patients who consume various antipsychotics. Methods: We compared DNA methylation in …

The pharmacoepigenetics of antipsychotic treatment in severe mental illness is a growing
area of research that aims to understand the interface between antipsychotic treatment and …

Various studies have investigated the relationship between genetic polymorphisms of
antipsychotic drug-metabolizing agents and drug response. DNA methylation is a form of …

Even though schizophrenia has a strong hereditary component, departures from simple
genetic transmission are prominent. DNA methylation has emerged as an epigenetic …

We performed a systematic analysis of blood DNA methylation profiles from 4483
participants from seven independent cohorts identifying differentially methylated positions …

Background Schizophrenia is a severe, highly heritable, neuropsychiatric disorder
characterized by episodic psychosis and altered cognitive function. Despite recent …

Schizophrenia is a severe psychiatric disease affecting about 1% of the world's population,
with significant effects on patients and society. Genetic studies have identified several …